Diabetes Mellitus, Insulin-Resistant
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
adults
children (increasingly) |
| gptkbp:alsoKnownAs |
gptkb:Type_2_Diabetes_Mellitus
|
| gptkbp:associatedWith |
gptkb:polycystic_ovary_syndrome
gptkb:metabolic_syndrome nonalcoholic fatty liver disease |
| gptkbp:cause |
macrovascular complications
microvascular complications |
| gptkbp:characterizedBy |
insulin resistance
hyperglycemia |
| gptkbp:complication |
gptkb:cardiovascular_disease
gptkb:nephropathy peripheral neuropathy retinopathy foot ulcers |
| gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting plasma glucose |
| gptkbp:firstDescribed |
20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Diabetes Mellitus, Insulin-Resistant
|
| gptkbp:ICD-10_code |
E11
|
| gptkbp:managedBy |
gptkb:food
exercise weight loss |
| gptkbp:prevalence |
high worldwide
increasing incidence |
| gptkbp:prevention |
healthy diet
weight control healthy lifestyle regular physical activity |
| gptkbp:riskFactor |
obesity
hypertension sedentary lifestyle older age dyslipidemia family history of diabetes |
| gptkbp:symptom |
fatigue
blurred vision polydipsia polyuria |
| gptkbp:treatment |
gptkb:metformin
gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification sulfonylureas insulin (in advanced cases) |
| gptkbp:bfsParent |
gptkb:D004053
|
| gptkbp:bfsLayer |
7
|